Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.

Drug Des Devel Ther · 2017 · PMC5441661 · PMID 28572721

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, the results of our study showed a trend toward increase in the hemorrhage risk as the dose increased.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.